Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia [NA]

View source ↗

Summary

A clinical trial is evaluating a three-drug combination of esketamine, pregabalin, and duloxetine for postherpetic neuralgia. The study is recruiting at Beijing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)
  • Esketamine (esketamine)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postherpetic Neuralgia | NA | Status: RECRUITING